NLS Pharmaceutics AG company info

What does NLS Pharmaceutics AG do?
NLS Pharmaceutics AG (NASDAQ:NLSP) focuses on the development and commercialization of innovative therapies for patients with neurological disorders and sleep-wake disorders. Dedicated to addressing the unmet medical needs in these areas, NLS engages in cutting-edge research to create solutions that improve quality of life. The company is particularly known for its work on narcolepsy, a condition that significantly impacts daytime alertness. By leveraging advanced technology and scientific insights, NLS aims to bring forth novel treatments that offer hope and relief to those affected by challenging neurological conditions. Their objective is to lead in the discovery and development of drugs that can transform the therapeutic landscape for patients worldwide.
NLS Pharmaceutics AG company media
Company Snapshot

Is NLS Pharmaceutics AG a public or private company?


How many people does NLS Pharmaceutics AG employ?


What sector is NLS Pharmaceutics AG in?

pie chart
Health Care

Where is the head office for NLS Pharmaceutics AG?

location pin
Head Office
Stans, Switzerland

What year was NLS Pharmaceutics AG founded?

founded flag
Year Founded
What does NLS Pharmaceutics AG specialise in?
/Pharmaceutical Products /Drug Development /Neurological Disorders /Sleep Disorders /Pediatric Medicine /Clinical Trials

What are the products and/or services of NLS Pharmaceutics AG?

Overview of NLS Pharmaceutics AG offerings
Quilience® is aimed at treating narcolepsy, focusing on enhancing wakefulness and reducing sudden sleep episodes.
Lu AG06466 targets excessive daytime sleepiness and cataplexy in narcolepsy patients, improving daily functioning.
A development program is dedicated to formulating and optimizing unique formulations of mazindol, a stimulant drug, to treat rare sleep disorders.
Through strategic collaborations, they explore extending mazindol’s application into other neurological diseases beyond sleep disorders.
The company provides consultancy services in pharmaceutical development, leveraging their expertise in CNS disorders.
They also offer licensing opportunities for their proprietary formulations and drug development pipeline to potential partners.

Who is in the executive team of NLS Pharmaceutics AG?

NLS Pharmaceutics AG leadership team
  • Mr. Alexander  Zwyer M.B.A.
    Mr. Alexander Zwyer M.B.A.
    President, CEO & Director
  • Dr. George  Apostol M.D.
    Dr. George Apostol M.D.
    Chief Medical Officer and Global Head of Research & Development
  • Dr. Eric  Konofal M.D., Ph.D.
    Dr. Eric Konofal M.D., Ph.D.
    Co-Founder & Chief Scientific Officer
  • Ms. Elena  Thyen-Pighin
    Ms. Elena Thyen-Pighin
    Chief Financial Officer
  • Dr. Christian C. Wenger Dr. iur., L.L.M., Ph.D.
    Dr. Christian C. Wenger Dr. iur., L.L.M., Ph.D.
    General Counsel